Omada - Changing Mindsets (60s)
This video is a quick look at all of the products offered by Omada. Prevention, Diabetes (Type 1 and 2), Hypertension, MSK + behavioral health support throughout all programs.
View
This Stream is used to house content that sales reps add to Streams within the Sales Assist app.
This video is a quick look at all of the products offered by Omada. Prevention, Diabetes (Type 1 and 2), Hypertension, MSK + behavioral health support throughout all programs.
View
This video is a quick look at the MSK program offered by Omada.
View
Due to the WTW & Omada partnership, we are all helping improve the health of 1.3m members across 109 clients.
View
Wendella Architecture Tour Boat Cruise
View
1-Page Overview for each Omada product including: Prevention, Diabetes (Type 1 and 2), Hypertension, and Musculoskeletal.
View
Omada is now offering a 2:1 ROI guarantee for our MSK program - we are able to provide this due to PT access. Omada provides appointments with licensed PTs anywhere in the country in 48 hours.
View
Omada is now offering a 2:1 ROI guarantee for our MSK program - we are able to do this not by requiring any claims data or subjective responses of surgery avoidance, but using a methodology based upon
View
Did you know that people with diabetes are 2-3x more likely to have depression? That's why Omada integrated behavioral health support into all of our chronic condition management programs.
View
Can everyone improve their health? At Omada Health, we believe that with long-term behavior change, the answer is a resounding yes.
View
Please contact me if you are interested in the 3-week VIP experience for yourself, team member, or client.
View
This video is a quick look at all of the products offered by Omada. Prevention, Diabetes (Type 1 and 2), Hypertension, MSK + behavioral health support throughout all programs.
View
Contact me if you are interested in the VIP trial for yourself or a client.
View
2-pager that provides an overview of Omada and our key differentiators.
View
This is the deck we reviewed as a group on 6.14.22
View
View